Find the latest Iovance Biotherapeutics, Inc. (IOVA) stock quote, history, news and other vital information to help you with your stock trading and investing.

Learn about our investigational tumor infiltrating lymphocyte (TIL) therapy and peripheral blood lymphocyte (PBL) therapy. View our clinical trials and pipeline.

4 days ago · IOVA | Complete Iovance Biotherapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Iovance Biotherapeutics (NASDAQ: IOVA), a small-cap biotech company, has an innovative approach to treating cancer that relies on harnessing patients' cancer-fighting capabilities.

View Iovance Biotherapeutics Inc IOVA stock quote prices, financial information, real-time forecasts, and company news from CNN.

Jan 24, 2025 · See the latest Iovance Biotherapeutics Inc stock price (IOVA:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

Get the latest Iovance Biotherapeutics Inc (IOVA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment...

Discover real-time Iovance Biotherapeutics, Inc. Common Stock (IOVA) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with...

Aug 27, 2024 · It's been a wild roller-coaster ride for Iovance Biotherapeutics (NASDAQ: IOVA). In February, the stock more than doubled in price, then it fell to a 52-week low in July.

4 days ago · About IOVA. Iovance Biotherapeutics, Inc., a commercial-stage biotechnology company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in …